News

FDA clears first digital treatment for depression, but experts caution that research is still early

todayApril 2, 2024 9

Background
share close
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

​ The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Read More Breaking News, Latest News and Videos | CNN 

Written by:

Rate it